AHA ACLS 2025 Cardioversion and Defibrillation Guidelines
For atrial fibrillation cardioversion, start with 200 J biphasic shock; for atrial flutter, use 200 J initial energy; these recommendations represent the most current 2025 AHA ACLS guidelines that prioritize efficacy, efficiency, and safety. 1
Atrial Fibrillation Cardioversion
Initial Energy Selection
- Start with 200 J for synchronized cardioversion of atrial fibrillation using any biphasic defibrillator 1, 2
- This energy level balances high success rates with safety
- Biphasic waveforms have made lower initial energies less necessary
Escalation Strategy
If the initial 200 J shock fails:
- Increment energy to maximum available on your defibrillator
- Before repeating shocks, optimize technique (see below)
Atrial Flutter Cardioversion
Energy Recommendations
Use 200 J as the initial energy for atrial flutter cardioversion 1
This higher starting energy is justified because:
- Success rates at lower energies are suboptimal (50-75% at 50 J, 85-90% at 100 J)
- 200 J approaches 100% success rate
- Shorter procedural times without safety concerns
- Critical advantage: Prevents undertreating atrial fibrillation if mistakenly identified as flutter 1
- Single-lead monitoring in emergent settings makes distinguishing AF from flutter challenging
Shock-Refractory Atrial Fibrillation Management
When maximum-energy shocks fail, follow this algorithmic approach:
Step 1: Optimize Pad Technique
- Apply direct pad pressure - improves success from 87% to 93% 1
- Ensure optimal pad-skin contact
- Minimize transthoracic impedance
Step 2: Reposition Pads
- Redirect shock vector with alternative pad placement - improves success to 96% 1
- Try anteroposterior positioning if using anterior-lateral initially
Step 3: Consider Antiarrhythmic Drugs
- Add medications to alter defibrillation threshold
- Options include amiodarone, procainamide, or sotalol 1
Step 4: Double Synchronized Cardioversion (Last Resort)
- Only provides modest incremental benefit (96% to 98%) after optimizing above steps 1
- Limited data with procedural uncertainties
- Studies show 75-100% success in previously failed cases
- Important caveat: 400 J double synchronized cardioversion showed 98% efficacy versus 87% with 200 J single shock (p=0.002), but vagueness in procedural specifications remains concerning 1
- No reported proarrhythmia, hemodynamic complications, or cardiac enzyme elevation
- Has caused defibrillator damage in some cases
Key Clinical Pitfalls
Distinguishing AF from Flutter
- Always assume atrial fibrillation when uncertain - use 200 J initial energy
- Single-lead monitoring makes definitive diagnosis difficult
- The two arrhythmias frequently transition between each other
- Using 200 J for both eliminates risk of undertreating AF
Recurrent vs. Refractory AF
- Recurrent AF = returns after initially successful shock
- Shock-refractory AF = remains incessant after maximum-energy shocks
- These require different management approaches
- Shock-refractory AF is relatively uncommon with modern biphasic waveforms
Rate vs. Rhythm Control Alternatives
When cardioversion is not immediately indicated or fails:
- Rate control: IV diltiazem, verapamil, metoprolol, or esmolol 1
- Chemical cardioversion: IV amiodarone, procainamide, or sotalol 1
- Amiodarone uniquely provides both rate and rhythm control, particularly useful in heart failure patients
Evidence Quality Note
The 2025 AHA guidelines 1 represent the most current and authoritative source, superseding the 2024 focused update 3. The biphasic waveform data supporting these energy recommendations comes from multiple studies showing comparable efficacy between rectilinear and truncated exponential waveforms available in the United States, with the 200 J recommendation providing the optimal balance of efficacy without compromising safety.